Jackie Vergote

634 total citations
27 papers, 513 citations indexed

About

Jackie Vergote is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Jackie Vergote has authored 27 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Oncology. Recurrent topics in Jackie Vergote's work include Radiopharmaceutical Chemistry and Applications (4 papers), Alzheimer's disease research and treatments (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Jackie Vergote is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Alzheimer's disease research and treatments (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Jackie Vergote collaborates with scholars based in France, Australia and United States. Jackie Vergote's co-authors include Jean‐Luc Moretti, Sylvie Chalon, Arlette Garnier‐Suillerot, Sylvie Bodard, Elisabeth G.E. de Vries, Denis Guilloteau, Afsaneh Gaillard, Stéphanie Pain, Nathupakorn Dechsupa and Nicolas Arlicot and has published in prestigious journals such as International Journal of Molecular Sciences, European Journal of Biochemistry and Neurobiology of Aging.

In The Last Decade

Jackie Vergote

23 papers receiving 487 citations

Peers

Jackie Vergote
E. Multon France
Jackie Vergote
Citations per year, relative to Jackie Vergote Jackie Vergote (= 1×) peers E. Multon

Countries citing papers authored by Jackie Vergote

Since Specialization
Citations

This map shows the geographic impact of Jackie Vergote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jackie Vergote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jackie Vergote more than expected).

Fields of papers citing papers by Jackie Vergote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jackie Vergote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jackie Vergote. The network helps show where Jackie Vergote may publish in the future.

Co-authorship network of co-authors of Jackie Vergote

This figure shows the co-authorship network connecting the top 25 collaborators of Jackie Vergote. A scholar is included among the top collaborators of Jackie Vergote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jackie Vergote. Jackie Vergote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kantapan, Jiraporn, et al.. (2021). Iron–Quercetin Complex Preconditioning of Human Peripheral Blood Mononuclear Cells Accelerates Angiogenic and Fibroblast Migration: Implications for Wound Healing. International Journal of Molecular Sciences. 22(16). 8851–8851. 13 indexed citations
2.
Chalon, Sylvie, Claire Tronel, Frédéric Buron, et al.. (2020). Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson's disease. Neural Regeneration Research. 16(6). 1099–1099. 14 indexed citations
3.
Vercouillie, Johnny, Frédéric Buron, Jackie Vergote, et al.. (2019). Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18F]ASEM in a Rat Model of Parkinson’s Disease. Molecular Imaging and Biology. 22(2). 348–357. 12 indexed citations
4.
Pain, Stéphanie, et al.. (2019). Inflammatory process in Parkinson disease: neuroprotection by neuropeptide Y. Fundamental and Clinical Pharmacology. 33(5). 544–548. 33 indexed citations
5.
Arlicot, Nicolas, Emilie Vierron, Sylvie Bodard, et al.. (2012). Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6‐hydroxydopamine rat model of Parkinson's disease. Synapse. 66(7). 573–583. 42 indexed citations
6.
Decressac, Mickaël, Stéphanie Pain, Laura Frangeul, et al.. (2011). Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiology of Aging. 33(9). 2125–2137. 67 indexed citations
7.
Barc, Céline, Nicolas Arlicot, Denis Guilloteau, et al.. (2010). Evaluation of Prion Deposits and Microglial Activation in Scrapie-Infected Mice Using Molecular Imaging Probes. Molecular Imaging and Biology. 12(6). 576–582. 6 indexed citations
8.
Vergote, Jackie, Sylvie Chalon, Patrick Emond, et al.. (2009). Les nouveaux traceurs TEMP et TEP de la démence. Médecine Nucléaire. 33(3). 137–141.
9.
Arlicot, Nicolas, Andrew Katsifis, Lucette Garreau, et al.. (2008). Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. European Journal of Nuclear Medicine and Molecular Imaging. 35(12). 2203–2211. 41 indexed citations
10.
Bernard, Serge, Pierre Sarradin, Jackie Vergote, et al.. (2007). IMPY, a potential β-amyloid imaging probe for detection of prion deposits in scrapie-infected mice. Nuclear Medicine and Biology. 35(2). 197–201. 8 indexed citations
11.
Chalon, Sylvie, Jackie Vergote, J. M. Henderson, et al.. (2007). Decreased vesicular acetylcholine transporter and α4β2 nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning. Neuroscience Letters. 415(2). 97–101. 9 indexed citations
12.
Dechsupa, Nathupakorn, S. Kothan, Jackie Vergote, et al.. (2007). Quercetin, Siamois 1 and siamois 2 induce apoptosis in human breast cancer MDA-MB-435 cells xenograft in vivo. Cancer Biology & Therapy. 6(1). 56–61. 43 indexed citations
13.
Kothan, S., Nathupakorn Dechsupa, Gabriel C. Léger, et al.. (2004). Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells. Canadian Journal of Physiology and Pharmacology. 82(12). 1084–1090. 26 indexed citations
14.
Perret, G., Anna Starzec, Jackie Vergote, et al.. (2004). In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1. Nuclear Medicine and Biology. 31(5). 575–581. 44 indexed citations
15.
Vergote, Jackie, et al.. (2003). In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging. European Journal of Nuclear Medicine and Molecular Imaging. 30(4). 502–509. 13 indexed citations
16.
Vergote, Jackie, J Moretti, Jean Claude Kouyoumdjian, & Arlette Garnier‐Suillerot. (2002). MRP1 modulation by PAK-104P: detection with technetium-99m-MIBI in cultured lung tumor cells.. PubMed. 22(1A). 251–6. 5 indexed citations
17.
Vergote, Jackie, Jean‐Luc Moretti, Elisabeth G.E. de Vries, & Arlette Garnier‐Suillerot. (1998). Comparison of the kinetics of active efflux of 99mTc‐MIBI in cells with P‐glycoprotein‐mediated and multidrug‐resistance protein‐associated multidrug‐resistance phenotypes. European Journal of Biochemistry. 252(1). 140–146. 56 indexed citations
18.
Moretti, Jean‐Luc, Anna Starzec, Virginie de Beco, et al.. (1998). Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.. PubMed. 39(7). 1214–8. 41 indexed citations
19.
Vergote, Jackie. (1963). A.-J. Festugière, Les moines d'Orient. III. Les moines de Palestine. 1er fascicule, Cyrille de Scythopolis : Vie de saint Euthyme. L'Antiquité Classique. 32(2). 677–677. 1 indexed citations
20.
Vergote, Jackie. (1960). Svennung (J). Anredeformen. Vergleichende Forschungen zur indirekten Anrede in der dritten Person und zum Nominativ für den Vokativ. Revue belge de philologie et d histoire. 38(3). 869–872. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026